Adverse reactions to antituberculosis drugs in Manguinhos, Rio de Janeiro, Brazil

OBJECTIVES: This study aimed to characterize and estimate the frequency of adverse reactions to antituberculosis drugs in the population treated at the Centro de Saúde Escola Germano Sinval Faria, a primary health care clinic in Manguinhos, Rio de Janeiro City, and to explore the relationship between adverse drug reactions and some of the patients' demographic and health characteristics. METHODS: This descriptive study was conducted via patient record review of incident cases between 2004 and 2008. RESULTS: Of the 176 patients studied, 41.5% developed one or more adverse reactions to antituberculosis drugs, totaling 126 occurrences. The rate of adverse reactions to antituberculosis drugs was higher among women, patients aged 50 years or older, those with four or more comorbidities, and those who used five or more drugs. Of the total reactions, 71.4% were mild. The organ systems most affected were as follows: the gastrointestinal tract (29.4%), the skin and appendages (21.4%), and the central and peripheral nervous systems (14.3%). Of the patients who experienced adverse reactions to antituberculosis drugs, 65.8% received no drug treatment for their adverse reactions, and 4.1% had one of the antituberculosis drugs suspended because of adverse reactions. "Probable reactions" (75%) predominated over "possible reactions" (24%). In the study sample, 64.3% of the reactions occurred during the first two months of treatment, and most (92.6%) of the reactions were ascribed to the combination of rifampicin + isoniazid + pyrazinamide (Regimen I). A high dropout rate from tuberculosis treatment (24.4%) was also observed. CONCLUSION: This study suggests a high rate of adverse reactions to antituberculosis drugs.

Saved in:
Bibliographic Details
Main Authors: Damasceno,Glauciene Santana, Guaraldo,Lusiele, Engstrom,Elyne Montenegro, Theme Filha,Mariza Miranda, Souza-Santos,Reinaldo, Vasconcelos,Ana Gloria Godoi, Rozenfeld,Suely
Format: Digital revista
Language:English
Published: Faculdade de Medicina / USP 2013
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013000300009
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1807-59322013000300009
record_format ojs
spelling oai:scielo:S1807-593220130003000092015-07-28Adverse reactions to antituberculosis drugs in Manguinhos, Rio de Janeiro, BrazilDamasceno,Glauciene SantanaGuaraldo,LusieleEngstrom,Elyne MontenegroTheme Filha,Mariza MirandaSouza-Santos,ReinaldoVasconcelos,Ana Gloria GodoiRozenfeld,Suely Tuberculosis Drug Toxicity Patient Treatment Refusal Primary Health Care OBJECTIVES: This study aimed to characterize and estimate the frequency of adverse reactions to antituberculosis drugs in the population treated at the Centro de Saúde Escola Germano Sinval Faria, a primary health care clinic in Manguinhos, Rio de Janeiro City, and to explore the relationship between adverse drug reactions and some of the patients' demographic and health characteristics. METHODS: This descriptive study was conducted via patient record review of incident cases between 2004 and 2008. RESULTS: Of the 176 patients studied, 41.5% developed one or more adverse reactions to antituberculosis drugs, totaling 126 occurrences. The rate of adverse reactions to antituberculosis drugs was higher among women, patients aged 50 years or older, those with four or more comorbidities, and those who used five or more drugs. Of the total reactions, 71.4% were mild. The organ systems most affected were as follows: the gastrointestinal tract (29.4%), the skin and appendages (21.4%), and the central and peripheral nervous systems (14.3%). Of the patients who experienced adverse reactions to antituberculosis drugs, 65.8% received no drug treatment for their adverse reactions, and 4.1% had one of the antituberculosis drugs suspended because of adverse reactions. "Probable reactions" (75%) predominated over "possible reactions" (24%). In the study sample, 64.3% of the reactions occurred during the first two months of treatment, and most (92.6%) of the reactions were ascribed to the combination of rifampicin + isoniazid + pyrazinamide (Regimen I). A high dropout rate from tuberculosis treatment (24.4%) was also observed. CONCLUSION: This study suggests a high rate of adverse reactions to antituberculosis drugs.info:eu-repo/semantics/openAccessFaculdade de Medicina / USPClinics v.68 n.3 20132013-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013000300009en10.6061/clinics/2013(03)OA08
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Damasceno,Glauciene Santana
Guaraldo,Lusiele
Engstrom,Elyne Montenegro
Theme Filha,Mariza Miranda
Souza-Santos,Reinaldo
Vasconcelos,Ana Gloria Godoi
Rozenfeld,Suely
spellingShingle Damasceno,Glauciene Santana
Guaraldo,Lusiele
Engstrom,Elyne Montenegro
Theme Filha,Mariza Miranda
Souza-Santos,Reinaldo
Vasconcelos,Ana Gloria Godoi
Rozenfeld,Suely
Adverse reactions to antituberculosis drugs in Manguinhos, Rio de Janeiro, Brazil
author_facet Damasceno,Glauciene Santana
Guaraldo,Lusiele
Engstrom,Elyne Montenegro
Theme Filha,Mariza Miranda
Souza-Santos,Reinaldo
Vasconcelos,Ana Gloria Godoi
Rozenfeld,Suely
author_sort Damasceno,Glauciene Santana
title Adverse reactions to antituberculosis drugs in Manguinhos, Rio de Janeiro, Brazil
title_short Adverse reactions to antituberculosis drugs in Manguinhos, Rio de Janeiro, Brazil
title_full Adverse reactions to antituberculosis drugs in Manguinhos, Rio de Janeiro, Brazil
title_fullStr Adverse reactions to antituberculosis drugs in Manguinhos, Rio de Janeiro, Brazil
title_full_unstemmed Adverse reactions to antituberculosis drugs in Manguinhos, Rio de Janeiro, Brazil
title_sort adverse reactions to antituberculosis drugs in manguinhos, rio de janeiro, brazil
description OBJECTIVES: This study aimed to characterize and estimate the frequency of adverse reactions to antituberculosis drugs in the population treated at the Centro de Saúde Escola Germano Sinval Faria, a primary health care clinic in Manguinhos, Rio de Janeiro City, and to explore the relationship between adverse drug reactions and some of the patients' demographic and health characteristics. METHODS: This descriptive study was conducted via patient record review of incident cases between 2004 and 2008. RESULTS: Of the 176 patients studied, 41.5% developed one or more adverse reactions to antituberculosis drugs, totaling 126 occurrences. The rate of adverse reactions to antituberculosis drugs was higher among women, patients aged 50 years or older, those with four or more comorbidities, and those who used five or more drugs. Of the total reactions, 71.4% were mild. The organ systems most affected were as follows: the gastrointestinal tract (29.4%), the skin and appendages (21.4%), and the central and peripheral nervous systems (14.3%). Of the patients who experienced adverse reactions to antituberculosis drugs, 65.8% received no drug treatment for their adverse reactions, and 4.1% had one of the antituberculosis drugs suspended because of adverse reactions. "Probable reactions" (75%) predominated over "possible reactions" (24%). In the study sample, 64.3% of the reactions occurred during the first two months of treatment, and most (92.6%) of the reactions were ascribed to the combination of rifampicin + isoniazid + pyrazinamide (Regimen I). A high dropout rate from tuberculosis treatment (24.4%) was also observed. CONCLUSION: This study suggests a high rate of adverse reactions to antituberculosis drugs.
publisher Faculdade de Medicina / USP
publishDate 2013
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013000300009
work_keys_str_mv AT damascenoglaucienesantana adversereactionstoantituberculosisdrugsinmanguinhosriodejaneirobrazil
AT guaraldolusiele adversereactionstoantituberculosisdrugsinmanguinhosriodejaneirobrazil
AT engstromelynemontenegro adversereactionstoantituberculosisdrugsinmanguinhosriodejaneirobrazil
AT themefilhamarizamiranda adversereactionstoantituberculosisdrugsinmanguinhosriodejaneirobrazil
AT souzasantosreinaldo adversereactionstoantituberculosisdrugsinmanguinhosriodejaneirobrazil
AT vasconcelosanagloriagodoi adversereactionstoantituberculosisdrugsinmanguinhosriodejaneirobrazil
AT rozenfeldsuely adversereactionstoantituberculosisdrugsinmanguinhosriodejaneirobrazil
_version_ 1756432195915874304